A review of lung transplant donor acceptability criteria

Journal of Heart and Lung Transplantation

Volumn 22, Issue 11, 2003, Pages 1183-1200

  Orens, Jonathan B ^a   Boehler, Annette ^b   De Perrot, Marc ^c   Estenne, Marc ^d   Glanville, Allan R ^e   Keshavjee, Shaf ^c   Kotloff, Robert ^f   Morton, Judith ^e   Studer, Sean M ^g   Van Raemdonck, Dirk ^h   Waddel, Thomas ^c   Snell, Gregory I ⁱ  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d ERASME HOSPITAL   (Belgium)

^e ST VINCENT S HOSPITAL   (Australia)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANAMNESIS; ARTERIAL GAS; ARTIFICIAL VENTILATION; ASTHMA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BIOAVAILABILITY; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; BRONCHOSCOPY; CANCER; CENTRAL NERVOUS SYSTEM TUMOR; GRAM STAINING; HISTORY OF MEDICINE; HUMAN; KIDNEY CARCINOMA; LUNG FUNCTION; LUNG TRANSPLANTATION; MEDICAL ASSESSMENT; MEDICAL LITERATURE; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SMOKING; THORAX RADIOGRAPHY; X RAY ANALYSIS;

EID: 10744227382     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00096-2     Document Type: Review

References (120)

1. Pierre A.F., Sekine Y., Hutcheon M., Waddell T.K., Keshavjee S. Marginal lung donors a reassessment. J Thorac Cardiovasc Surg. 123:(3):2002;421-428.
2. Garrity ER. Pre-transplant evaluation of the donor/organ procurement. In: Norman DJ, Suki WN, editors. Primer on Transplantation first edition. Thorofare, N.J. American Society of Transplant Physicians, 1998, p. 499-505.
3. Myoshi S., Trulock E.P., Shaefers H., Hsie C., Patterson G.A., Cooper J.D. Cardiopulmonary exercise testing after single and double lung transplantation. Chest. 97:1990;1130-1136.
4. United Network for Organ Sharing. Guidelines for multiorgan donor management and procurement. UNOS Update 1993;14-5.
5. Richter N., Raddatz G., Steinhoff G., Schafers H.J., Schlitt H.J. Transmission of donor lymphocytes in clinical lung transplantation. Transplant Int. 7:1994;414-419.
6. Grewe M. Chronological aging and photoaging of dendritic cells. Clin Exp Dermatol. 26:2001;608-612.
7. Rosas G.O., Zierman S.J., Donabedian M., Vandegaer K., Hare J.M. Augmented age-associated innate immune responses contribute to negative inotropic and lusitropic effects of lipopolysaccharide and interferon gamma. J Mol Cell Cardiol. 33:2001;1849-1859.
8. + T helper cell clones derived from young donors and elderly donors, or from progenitor cells age associated differences in cell surface molecule expression and cytokine secretion. Biogerontology. 1:2000;247-254.
9. Novick R.J., Bennett L.E., Meyer D.M., Hosenpud J.D. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant. 18:1999;425-431.
10. Meyer D.M., Bennett L.E., Novick R.J., Hosenpud J.D. Effect of donor age and ischemic time in intermediate survival and morbidity after lung transplantation. Chest. 118:2000;1255-1262.
11. Sommers K.E., Griffith B.P., Hardesty R.L., Keenan R.J. Early lung allograft function in twin recipients from the same donor risk factor analysis. Ann Thorac Surg. 62:1996;784-790.
12. Bhorade S.M., Vigneswaran W., McCabe M.A., Garrity E.R. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 19:2000;1199-1204.
13. Sundaresan S., Semenkovich J., Ochoa L., et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg. 109:1995;1075-1079.
14. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The registry of the International Society for Heart and Lung Transplantation eighteenth official report - 2001. J Heart Lung Transplant. 20:2001;805-815.
15. Harjula A., Baldwin J.C., Starnes V.A., et al. Proper donor selection for heart-lung transplantation. The Stanford experience. J Thorac Cardiovasc Surg. 94:1987;874-880.
16. Gabbay E., Williams T.J., Griffiths A.P., et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med. 160:1999;265-271.
17. Pennefather S.H., Bullock R.E., Dark J.H. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation. 56:1993;1418-1422.
18. Waller D.A., Bennett M.K., Corris P.A., Dark J.H. Donor-acquired fat embolism causing primary organ failure after lung transplantation. Ann Thorac Surg. 59:1995;1565-1566.
19. Simonetti V.A., Basha M.A., Allenspach L., Klosterman K.G., Nakhleh R., Higgins R.S. Donor cerebral tissue pulmonary emboli in a functioning transplanted lung. Clin Transplant. 12:1998;504-507.
20. Rosendale B.E., Keenan R.J., Duncan S.R., et al. Donor cerebral emboli as a cause of acute graft dysfunction in lung transplantation. J Heart Lung Transplant. 11:1992;72-76.
21. Nguyen D.Q., Salerno C.T., Bolman M., Park S.J. Pulmonary thromboembolectomy of donor lungs prior to lung transplantation. Ann Thorac Surg. 67:1999;1787-1789.
22. Follette D.M., Rudich S.M., Babcock W.D. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant. 17:1998;423-429.
23. Shumway S.J., Hertz M.I., Petty M.G., Bolman R.M. Liberalization of donor criteria in lung and heart-lung transplantation. Ann Thorac Surg. 57:1994;92-95.
24. Puskas J.D., Winton T.L., Miller J.D., Scavuzzo M., Patterson G.A. Unilateral donor lung dysfunction does not preclude successful contralateral single lung transplantation. J Thorac Cardiovasc Surg. 103:1992;1015-1017.
25. el-Gamel A.L., Egan L., Rahman A., Deiraniya A.K., Yonan N. Application of pulmonary vein gas analysis a novel approach which may increase the pool of potential lung transplant donors. J Heart Lung Transplant. 15:(3):1996;315-316.
26. Frost A.E. Donor criteria and evaluation. Clin Chest Med. 18:1997;231-237.
27. Meyers B.F., Lynch J., Trulock E.P., Guthrie J.D., Patterson G.A. Lung transplantation a decade of experience. Ann Surg. 230:1999;362-370.
28. Cooper J.D. The lung donor special considerations. Transplant Proc. 20:1988;17-18.
29. Griffith B.P., Zenati M. The pulmonary donor. Clin Chest Med. 11:1990;217-226.
30. Winton T.L., Miller J.D., Scavuzzo M., et al. Donor selection for pulmonary transplantation. Transplant Proc. 23:1991;2472-2474.
31. Egan T. Selection and management of the lung donor. Patterson G.A., Couraud L. Current topics in general thoracic surgery. 1995;103-115 Elsevier, Amsterdam.
32. Egan T., Boychuk J.E., Rosato K., et al. Whence the lungs? A study to assess suitability of donor lungs for transplantation. Transplantation. 53:1992;420-422.
33. Hsieh A.H., Bishop M.J., Kubilis P.S., et al. Pneumonia following closed head injury. Am Rev Respir Dis. 146:1992;290-294.
34. Van Raemdonck D, Roels L, Verleden G, et al. Whence the lungs? Assessment of the use of lungs for transplantation from 156 consecutive donors [abstract]. In: Cooper JD, Weder W, eds. Proceedings of the Third International Lung Transplant Symposium. 1993:40.
35. Riou B., Guesde R., Jacquens Y., et al. Fiberoptic bronchoscopy in brain-dead organ donors. Am J Respir Crit Care Med. 150:1994;558-560.
36. Stewart S., Ciulli F., Wells F.C., et al. Pathology of unused donor lungs. Transplant Proc. 25:1993;1167-1168.
37. Low D.E., Kaiser L.E., Haydock D.A., et al. The donor lung infectious and pathologic factors affecting outcome in lung transplantation. J Thorac Cardiovasc Surg. 106:1993;614-621.
38. Zenati M., Dowling R.D., Dummer J.S., et al. Influence of the donor lung on development of early infections in lung transplant recipients. J Heart Lung Transplant. 9:1990;502-509.
39. Sole-Violan J., Rodriguez de Castro F., Rey A., et al. Comparison of bronchoscopic diagnostic techniques with histological findings in brain dead organ donors without suspected pneumonia. Thorax. 51:1996;929-931.
40. Maurer J.R., Tullis D.E., Grossman R.F., et al. Infectious complications following isolated lung transplantation. Chest. 101:1992;1056-1059.
41. Dowling R.D., Zenati M., Yousem S.A., et al. Donor-transmitted pneumonia in experimental lung allografts; successful prevention with donor antibiotic therapy. J Thorac Cardiovasc Surg. 103:1992;767-772.
42. Weill D., Dey G.C., Young K.R., et al. A positive donor gram stain does not predict the development of pneumonia, oxygenation or duration of mechanical ventilation following lung transplantation. J Heart Lung Transplant. 20:2001;255.
43. Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Novick R.J. The registry of the International Society for Heart and Lung Transplantation fourteenth official report - 1997. J Heart Lung Transplant. 16:1997;691-694.
44. Snell G.I., Rabinov M., Griffiths A., et al. Pulmonary allograft ischemic time an important predictor of survival after lung transplantation. J Heart Lung Transplant. 15:1996;169-174.
45. Gammie J.S., Dtukus D.R., Pham S.M., et al. Effect of ischemic time on survival in clinical lung transplantation. Ann Thorac Surg. 68:1999;2015-2020.
46. Fiser S.M., Kron I.L., Long S.M., Kaza A.K., Kern J.A., Cassada D.C., et al. Influence of graft ischemic time on outcome following lung transplantation. J Heart Lung Transplant. 20:(12):2001;1291-1296.
47. Kshettry V.R., Kroshus T., Burdine J., Savik K., Bolman M. Does organ ischemia over four hours affect long-term survival after lung transplantation? J Heart Lung Transplant. 15:1996;169-174.
48. Winton T.L., Miller J., deHoyos A., Snell G.I., Maurer J.R. Graft function, airway healing, rejection, and survival in pulmonary transplantation are not affected by graft ischemia in excess of 5 hours. Transplant Proc. 25:(1):1993;1649-1650.
49. Glanville A.R., Marshman D., Keogh A., et al. Outcome in paired recipients of single lung transplants from the same donor. J Heart Lung Transplant. 14:1995;878-882.
50. Wahlers T., Schafers H.J., Cremer J., et al. Organ preservation for heart-lung and lung transplantation. J Thorac Cardiovasc Surg. 39:1991;344-348.
51. Ueno T., Snell G.I., Williams T.J., et al. Impact of graft ischemia time on outcomes after bilateral sequential single-lung transplantation. Ann Thorac Surg. 67:1999;1577-1582.
52. deHoyos A., Patterson G.A., Maurer J.R., Ramirez J.C., Miller J., Winton T.L. Pulmonary transplantation. Early and late results. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg. 103:1992;295-306.
53. Egan T. Lung preservation. Semin Thorac Cardiovasc Surg. 4:1992;83-89.
54. Knight S.R., Dresler C. Results of lung transplantation. Semin Thorac Cardiovasc Surg. 4:1992;107-112.
55. Fischer S., Matte-Martyn A., de Perot M., Waddell T.K., Sekine Y., Hutcheon M., et al. Low potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg. 121:(3):2001;594-596.
56. Lillehei C.W., Shamberger R.C., Mayer J.E., Burke R.P., Koka B.V., Arnold J., et al. Size disparity in pediatric lung transplantation. J Pediatr Surg. 29:1994;1152-1155.
57. Loring S.H., Leith D.E., Connolly M.J., Ingenito E.P., Mentzer S.J., Reilly J.J. Model of functional restriction in chronic obstructive pulmonary disease, transplantation, and lung reduction surgery. Am J Respir Crit Care Med. 160:1999;821-828.
58. Massard G., Badier M., Guillot C., Reynaud M., Thomas P., Giudicelli R. Lung size matching for double lung transplantation based on the submammary thoracic perimeter. Accuracy and functional results. J Thorac Cardiovasc Surg. 105:1993;9-14.
59. Otulana B.A., Mist B.A., Scott J.P., Wallwork J., Higgenbottam T. The effect of recipient lung size on lung physiology after heart-lung transplantation. Transplantation. 48:1989;625-629.
60. Tamm M., Higgenbottam T., Dennis C.M., Sharples L.D., Wallwork J. Donor and Recipient predicted lung volume and lung size after heart-lung transplantation. Am J Respir Crit Care Med. 150:1994;403-407.
61. Lloyd K.S., Barnard P., Holland V.A., Noon G.P., Lawrence E.C. Pulmonary function after heart-lung transplantation using larger donor organs. Am Rev Respir Dis. 142:1990;1026-1029.
62. Miyoshi S., Schaefers H.J., Trulock E.P., Yamazaki F., Schreinemakers H., Patterson G.A., et al. Donor selection for single and double lung transplantation. Chest size matching and other factors influencing posttransplantation vital capacity. Chest. 98:1990;308-313.
63. Park S.J., Houck J., Pifarre R., Sullivan H., Garrity E.R., Kim S.Y., et al. Optimal size matching in single lung transplantation. J Heart Lung Transplant. 14:1995;671-675.
64. Hayden A.M., Scarlett M.V., Fox K. Relationship between donor/recipient lung size mismatch and functional outcome in single lung transplantation for COPD. J Transplant Coord. 6:1996;155-158.
65. Wisser W., Klepetko W., Wekerle T., Laufer G., Stift A., Hiesmayr M., et al. Tailoring of the lung to overcome size disparities in lung transplantation. J Heart Lung Transplant. 15:1996;239-242.
66. Egan T., Thompson J.T., Detterbeck F.C., Lackner R.P., Mill M.R., Ogden W.D., et al. Effect of size (mis)matching in clinical double-lung transplantation. Transplantation. 59:1995;707-713.
67. Sundaresan S., Trachiotis G.D., Aoe M., Patterson G.A., Cooper J.D. Donor lung procurement assessment and operative technique. Ann Thorac Surg. 56:1993;1409-1413.
68. Husain A.N., Hinkamp T.J. Donor lung pathology correlation with outcome of transplanted contralateral lung. J Heart Lung Transplant. 12:1993;932-939.
69. Speziali G., McDougall J.C., Midthun D.E., Peters S.G., Scott J.P., Daly R.C., et al. Native lung complications after single lung transplantation for emphysema. Transplant Int. 10:1997;113-115.
70. Svendsen C.A., Bengston R.B., Park S.J., Shumway S.J. Stage 1 adenocarcinoma presenting in the pneumonectomy specimen at the time of single lung transplantation. Transplantation. 66:1998;1108-1109.
71. Choi Y.H., Leung A.N., Miro S., Poirier C., Hunt S., Theodore J. Primary bronchogenic carcinoma after heart or lung transplantation radiologic and clinical findings. J Thorac Imag. 15:2000;36-40.
72. Delcambre F., Pruvot F.R., Ramon P., Noel C., Pol A., Jaillard-Thery S., et al. Primary bronchogenic carcinoma in transplant recipients. Transplant Proc. 28:1996;2884-2885.
73. DeSoyza A.G., Dark J.H., Parums D.V., Curtis A., Corris P.A. Donor acquired small cell lung cancer following pulmonary transplantation. Chest. 120:2001;1030-1031.
74. Stagner L.D., Allenspach L., Hogan K., Willcock L., Higgins R.S., Chan K. Bronchogenic carcinoma in lung transplant recipients. J Heart Lung Transplant. 20:2001;908-911.
75. Arcasoy S.M., Hersch C., Christie J.D., Zisman D., Pochettino A., Rosengard B.R., et al. Bronchogenic carcinoma complicating lung transplantation. J Heart Lung Transplant. 20:2001;1044-1053.
76. Warner M.A., Offord K.P., Warner M.E., Lennon R.L., Conover M.A., Jansson-Schumacher U. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc. 64:1989;609-616.
77. Nakagawa M., Tanaka H., Tsukuma H., Kishi Y. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest. 120:2001;705-710.
78. Dales R.E., Dionne G., Leech J.A., Lanau M., Schweitzer I. Preoperative prediction of pulmonary complications following thoracic surgery. Chest. 104:1993;155-159.
79. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking 40 years' observations on male British doctors. BMJ. 309:1994;901-911.
80. Lam T.H., Ho S.Y., Hedley A.J., Mark K.H., Peto R. Mortality and smoking in Hong Kong case-control study of all adult deaths in 1998. BMJ. 323:1998;1-6.
81. Liaw K.M., Chen C.J. Mortality attributable to cigarette smoking in Taiwan a 12-year follow-up study. Tobacco Control. 7:1998;141-148.
82. Liu B.Q., Peto R., Chen Z.M., Boreham J., Wu Y.P., Li J.Y., et al. Emerging tobacco hazards in China 1. BMJ. 317:1998;1411-1422.
83. Wald N.J., Watt H.C. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. BMJ. 314:1997;1860-1863.
84. Xu X., Dockery D.W., Ware J.H., Speizer F.E., Ferris B.G.J. Effects of cigarette smoking on rate of loss of pulmonary function in adults a longitudinal assessment. Am Rev Respir Dis. 146:1992;1345-1348.
85. Fletcher C., Peto R. The natural history of chronic airflow obstruction. BMJ. 1:1977;1645-1648.
86. 1 the Lung Health Study. JAMA. 272:1994;1497-1505.
87. Scanlon P.D., Connett J.E., Waller L.A., Altose M.D., Bailey W.C., Buist A.S., et al. Smoking cessation and lung function in mild-moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 161:2000;381-390.
88. Penn I. Transmission of cancer from organ donors. Ann Transplant. 2:1997;7-12.
89. Detry O., Honore P., Hans M.F., Delbouille M.H., Jacquet N., Meurisse M. Organ donors with primary central nervous system tumor. Transplantation. 70:2000;244-248.
90. Healy P.J., Davis C.L. Transmission of tumours by transplantation. Lancet. 352:1998;2-3.
91. Chui A.K., Herbertt K., Wang L.S., Kyd G., Hodgeman G., Verran D.J., et al. Risk of tumor transmission in transplantation from donors with primary brain tumors an Australian and New Zealand Registry report. Transplant Proc. 31:1999;1266-1267.
92. Kauffman H.M., McCabe M.A., Delmonico F.L. First report of the United Network for Organ Sharing Transplant Tumor Registry. Transplantation. 70:2000;1747-1751.
93. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation. 59:1995;480-485.
94. Buell J.F., Trofe J., Hanaway M.J., Lo A., Rosengard B.R., Rilo H., et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery. 130:2001;660-668.
95. Barrou B., Bitker M.O., Delcourt A., Ourahma S., Richard F. Fate of a renal tubulopapillary adenoma transmitted by an organ donor. Transplantation. 72:2001;540-542.
96. Penn I. Donor transmitted disease cancer. Transplant Proc. 23:1991;2629.
97. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion. 38:1998;975-988.
98. Starzl T.E., Tzakis A., Makowka L., et al. The definition of ABO factors in transplantation relation to other humoral antibody states. Transplant Proc. 19:1987;4492-4497.
99. Hunt B.J., Yacoub M., Amin S., et al. Induction of red blood cell destruction by graft-derived antibodies after minor ABO-mismatched heart and lung transplantation. Transplantation. 1988:1988;246-249.
100. Salerno C.T., Burdine J., Perry E.H., et al. Donor-derived antibodies and hemolysis after ABO-compatible but nonidentical heart-lung and lung transplantation. Transplantation. 65:1998;261-264.
101. Taaning E., Morling N., Mortensen S.A., et al. Hemolytic anemia due to graft-derived anti-B production after lung transplantation. Transplant Proc. 26:1994;1739.
102. Magrin G.T., Street A.M., Williams T.J., et al. Clinically significant anti-A derived from B lymphocytes after single lung transplantation. Transplantation. 56:1993;466-467.
103. Cummins D., Contreras M., Amin S., et al. Red cell alloantibody development associated with heart and lung transplantation. Transplantation. 59:1995;1432-1435.
104. Yu N.C., Haug M.T. III, Khan S.U., et al. Does the donor-recipient ABO blood group compatibility status predict subsequent lung transplantation outcomes? J Heart Lung Transplant. 18:1999;764-768.
105. Novick R.J., Schafers H.J., Stitt L., et al. Recurrence of obliterative bronchiolitis and determinants of outcome in 139 pulmonary retransplant recipients. J Thorac Cardiovasc Surg. 110:1995;1402-1413.
106. Ghosh S., Latimer R., Tew D. Airway obstruction in lungs obtained from an asthmatic donor complicating heart-lung transplantation. Anesthesiology. 73:1990;1270-1271.
107. Corris P.A., Dark J.H. Aetiology of asthma lessons learned from lung transplantation. Lancet. 341:1993;1369-1371.
108. 1 after heart-lung transplantation. Eur Respir J. 5:1992;834-840.
109. Higgenbottam T. Lung transplantation and asthma [letter]. Lancet. 342:1993;249.
110. Stanbrook M.B., Kesten S. Bronchial hyperreactivity after lung transplantation predicts early bronchiolitis obliterans. Am J Respir Crit Care Med. 160:1999;2034-2039.
111. Kotloff RM. Personal communication; 2002.
112. Torres A, El-Ebiary, Rano A. Respiratory infectious complications in the intensive care unit. Clin Chest Med 1999;20:287-301.
113. Ciulli F., Tamm M., Dennis C.M., et al. Donor transmitted bacterial infection after lung transplantation. Transplant Proc. 25:1993;1155.
114. Ciccone A.M., Stewart K.C., Meyers B.F., Guthrie T.J., Battafarano R.J., Trulock E.P., et al. Does donor cause of death affect the outcome of lung transplantation? J Thorac Cardiovasc Surg. 123:(3):2002;429-434.
115. 2000 annual report of the U.S. Scientific Registry for transplant recipients and the organ procurement and transplantation network. 2000;UNOS, Washington, DC.
116. Waller D.A., Thompson A.M., Wrightson W.N., Gould F.K., Corris P.A., Hilton C.J., et al. Does the mode of donor death influence the early outcome of lung transplantation? A review of lung transplantation from donors involved in major trauma. J Heart Lung Transplant. 14:1995;318-321.
117. Da Silva J.A. Sex hormones and glucocorticoids interaction with the immune system. Ann NY Acad Sci. 876:1999;102-117.
118. Rohleder N., Schommer N.C., Hellhammer D.H., Engel R., Kirschbaum C. Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom Med. 63:2001;966-972.
119. McMurray R.W., Ndebele K., Hardy K.J., Jenkins J.K. 17-Beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine. 14:2001;324-333.
120. McElhinney D.B., Khan J.H., Babcock W.D., Hall T.S. Thoracic organ donor characteristics associated with successful lung procurement. Clin Transplant. 15:2001;68-71.